ASMBS: More than nine out of 10 adults with severe obesity do not receive treatment

FRIDAY, May 8, 2026 (NewsDay News) – Despite a sharp increase in the use of glucagon-like peptide-1 (GLP-1) receptor agonists, most U.S. adults with severe obesity remain untreated, according to a study presented at the May 7, 2026, annual meeting…











